论文部分内容阅读
目的:研究中成药同西药联合使用的不良反应,为临床治疗工作的开展加以参考。方法:采用回顾性分析,对2011年11月~2013年12月来我院治疗且确诊为心脑血管病症的350例患者进行对比治疗,进行统计学分析。将患者进行分组,其中观察组包含200例患者,进行联合用药;对照组中含有患者150例,患者进行单一用药。研究探讨中成药和西药的联合使用对心脑血管病症的促进作用以及可能存在的不良反应。结果:本次临床研究治疗心脑血管疾病所使用的中成药同西药联合使用中不良反应占比值为47.5%,对照组中单独用药的不良反应占比值为10.7%,观察组中患者所具有的不良反应比值要明显高于对照组中患者所占有的不良反应比值。两组的比较差异间存在统计学的意义,(P<0.05)。结论:医院工作人员以及患者应该对中成药和西药所含有的成分进行了解,对他们的使用要慎重。
Objective: To study the side effects of proprietary Chinese medicines (TCM) in combination with western medicine for reference. Methods: A retrospective analysis was performed on 350 patients who were treated in our hospital from November 2011 to December 2013 and were diagnosed with cardiovascular and cerebrovascular diseases. The results were compared statistically. The patients were divided into groups, of which the observation group consisted of 200 patients for combination therapy; the control group consisted of 150 patients and the patients were given a single dose. Study to explore the promotion of traditional Chinese medicine and western medicine on cardiovascular and cerebrovascular diseases and the possible adverse reactions. Results: Adverse reactions accounted for 47.5% of the clinical trials for the treatment of cardiovascular and cerebrovascular diseases with the combination of proprietary Chinese medicines and western medicine. The proportion of adverse reactions in the control group was 10.7%. The patients in the observation group had Adverse reaction ratio was significantly higher than the proportion of patients with adverse reactions in the control group. There was statistical significance between the two groups (P <0.05). Conclusion: Hospital staff and patients should understand the ingredients contained in proprietary Chinese medicines and western medicines, and their use should be cautious.